Niacin (Vitamin B3) Supplementation in Patients with Serotonin-Producing Neuroendocrine Tumor

Neuroendocrinology
Grietje BoumaAnnemiek M E Walenkamp

Abstract

Tryptophan is the precursor of serotonin and niacin (vitamin B3). The latter is critical for normal cellular metabolism. Tryptophan and niacin can be deficient in patients with serotonin-producing neuroendocrine tumors (NETs). Niacin deficiency may lead to severe symptoms including pellagra. In patients with serotonin-producing NET, data on niacin status are scarce and niacin supplementation hardly receives attention. We aimed to assess the niacin status before and after supplementation in these patients. We identified serotonin-producing NET patients who had received oral niacin supplementation (mean dose 144 mg daily) for tryptophan deficiency and/or pellagra-associated symptoms. Presupplementation plasma tryptophan levels and niacin status based on the urinary niacin metabolite N1-methylnicotinamide (N1-MN) before (n = 42) and after the start of the supplementation (in 34 paired samples) were assessed. Reference values for urinary N1-MN levels were established in 133 healthy individuals. The mean presupplementation plasma tryptophan level was 31.8 ± 9.7 µmol/l (reference value 40.0-70.0). Presupplementation urinary N1-MN levels were lower in patients (median 17.9 µmol/24 h, range 2.6-70.3) compared to healthy controls (media...Continue Reading

Citations

Nov 22, 2016·Acta Pharmacologica Sinica·Sai-Fei LeiMing-Wei Wang
Feb 13, 2018·Endocrine-related Cancer·L D de HossonA M E Walenkamp
Jul 28, 2016·Endocrine-related Cancer·Georgios K DimitriadisAshley Grossman
Feb 22, 2018·Reviews in Endocrine & Metabolic Disorders·Xi-Feng JinChristoph J Auernhammer
Jul 10, 2019·Current Treatment Options in Oncology·Kira OleinikovSimona Grozinsky-Glasberg
Nov 10, 2017·Current Opinion in Endocrinology, Diabetes, and Obesity·Tetsuhide ItoRobert T Jensen
Aug 20, 2019·Pancreas·Boris G NaraevThorvardur R Halfdanarson
Mar 1, 2020·Biomolecules·Alvinsyah Adhityo PramonoJoseph R Bertino
May 21, 2020·Nutrients·Jakub PobłockiMałgorzata Szczuko
Apr 10, 2020·Cancer Immunology, Immunotherapy : CII·Lotte D de HossonAnnemiek M E Walenkamp
Apr 24, 2020·Journal of Oncology·Dominique ClementRaj Srirajaskanthan
Mar 20, 2019·World Journal of Gastroenterology : WJG·Dominique Svm ClementJohn K Ramage
Jan 21, 2021·Photodermatology, Photoimmunology & Photomedicine·Dhanashree PrabhuKelvin Mponda
Apr 25, 2021·Pharmacology & Therapeutics·Gulam Mohmad RatherPhilip Michael Tedeschi
Jun 14, 2021·Comprehensive Psychiatry·Anna La SalviaFrancesco Oliva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Related Papers

Proceedings of the Society for Experimental Biology and Medicine
R G Thomas, W G Wysor
Archiv Für Dermatologische Forschung
G G BruneA Wiskemann
Clinical Therapeutics
Emilio BajettaMichele Del Vecchio
Metabolism: Clinical and Experimental
L V HankesR C Mekel
© 2021 Meta ULC. All rights reserved